Vertex reports pancreatic function recovery in young CF patients

While it is difficult to reflect direct short-term metrics in current sales or financial structure, clinical progress in the pipeline serves as the key basis for long-term corporate value and valuation re-rating.

The announcement of pancreatic function recovery in a pediatric CF patient serves as important momentum proving the pipeline's substantive efficacy, but the lack of clear future goals or numerical guidance may limit the sustainability of this short-term positive catalyst.